Josh Horowitz

VC Investor. Passionate about Cybersecurity, BioTech & Cannabis

More From Josh Horowitz

Business News

Why this Canadian-Israeli Stock Grew 121% This Year

Innocan Pharma operates three primary and distinct segments: research and development (R&D) of CBD-loaded exosomes, R&D of the use of CBD-loaded liposomes, and commercialization and sale of branded CBD-integrated pharmaceutical and topical treatment products
Business News

Story Of a Rising CEO Of Canadian CBD One-stop-shop

Ayurcann Holdings, led by CEO Igal Sudman, is one of Canada's youngest but most distinguished and nominated cannabis extraction and processing companies. The CEO reveals Ayurcann's 2022 strategic plan to key investors
Business News

The Scientists who Cracked Diabetes

Dr. Philip Moshe and Eran Atlas are possibly the most influential duo in the Diabetes world over the past two decades as the developers of the AI algorithms behind Medtronic's artificial pancreas and world's first Endocrinology digital expert
Business News

This CEO Brings Cutting-Edge Results in the Oil and Gas Industry

Eco Atlantic Oil & Gas' CEO Gil Holzman is one of the world's most creative and resourceful energy executives that has helped transform petroleum exploration company Eco Atlantic Oil & Gas into a global enterprise developing new projects with prominent partners
Business News

From Johnson & Johnson To Israeli Tech Ecosystem

Earlier this year, Richard Serbin joined Canadian-Israeli pharmaceuticals company InnoCan Pharma as a consultant. Now the former Johnson & Johnson Vice President and FDA Counsel is already making a major impact: this month he was a featured speaker with InnoCan's CEO Iris Bincovich at the iCDP Conference in Boston

More Authors You Might Like